Jack Collins
Director/Board Member at T1D Exchange
Profile
Jack Collins is currently the Director at T1D Exchange since 2018.
Prior to this, he worked as the Chief Financial Officer at Fargo Ta LLC and as the Chief Operating & Financial Officer at PointCare Technologies, Inc. Mr. Collins holds an MBA from Babson College and an undergraduate degree from Suffolk University.
Jack Collins active positions
Companies | Position | Start |
---|---|---|
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | Director/Board Member | 2018-12-10 |
Former positions of Jack Collins
Companies | Position | End |
---|---|---|
Fargo Ta LLC
Fargo Ta LLC Electronics/AppliancesConsumer Durables Fargo Ta LLC design and manufactures audio products. It offers table radios, bluetooth streaming, portable radios, special collections, internet radios, Hi-Fi systems, and clock radios. The company was founded by Thomas J. DeVesto on July 10, 2000 and is headquartered in Boston, MA. | Director of Finance/CFO | - |
PointCare Technologies, Inc.
PointCare Technologies, Inc. Pharmaceuticals: MajorHealth Technology PointCare Technologies, Inc. develops, manufactures and markets medical diagnostic products. It offers PointCare NOW, an analyzer and reagent system for diagnostic management of HIV/AIDS patients at the point-of-care, CD4NOW Reagent Kit 100, an analyzer and reagent system. The company was founded by Petra B. Krauledat and Peter W. Hansen in 2003 and is headquartered in Marlborough, MA. | Director of Finance/CFO | - |
Training of Jack Collins
Babson College | Masters Business Admin |
Suffolk University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
PointCare Technologies, Inc.
PointCare Technologies, Inc. Pharmaceuticals: MajorHealth Technology PointCare Technologies, Inc. develops, manufactures and markets medical diagnostic products. It offers PointCare NOW, an analyzer and reagent system for diagnostic management of HIV/AIDS patients at the point-of-care, CD4NOW Reagent Kit 100, an analyzer and reagent system. The company was founded by Petra B. Krauledat and Peter W. Hansen in 2003 and is headquartered in Marlborough, MA. | Health Technology |
Fargo Ta LLC
Fargo Ta LLC Electronics/AppliancesConsumer Durables Fargo Ta LLC design and manufactures audio products. It offers table radios, bluetooth streaming, portable radios, special collections, internet radios, Hi-Fi systems, and clock radios. The company was founded by Thomas J. DeVesto on July 10, 2000 and is headquartered in Boston, MA. | Consumer Durables |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | Health Technology |
- Stock Market
- Insiders
- Jack Collins